Studies Seeking Community Participation
The scope of Menzies research is broad, and not all of our work requires participation from volunteers. However the studies listed below are looking for participants now. Studies are carefully designed and therefore research participants sometimes need to meet specific criteria to be eligible.
METHODS: A randomised controlled trial of methotrexate to treat hand osteoarthritis with synovitis is seeking participants aged 40 -75 years with moderate to severe hand joint pain who are interested in taking part in a study that aims to reduce pain and swelling and slow joint damage in people with symptomatic hand osteoarthritis and synovitis. Contact: Kathy Buttigieg on 03 6226 6909 or Kathy.Buttigieg@utas.edu.au.
Click here for more information.
Knee pain? We are looking for people aged 45 years and older who have received a diagnosis of osteoarthritis of the knee to take part in a short interview. The interview will focus on your perspective about the causes and progression of osteoarthritis. Your experience in the use of drug (pain relief medications) and non-drug management (like diet and exercise) of osteoarthritis. We would also like to hear your perspective on the role of health professionals in the management of osteoarthritis patients. Please contact: Jen Makin on +61 3 6226 4267 or Jen.Makin@utas.edu.au
Parkrun for knee pain: We are seeking people aged 45 and over who are not currently very active but interested in taking part in a weekly walking group for 4 weeks. This is a short feasibility study to determine the use of parkrun as a strategy to promote physical activity in people with knee osteoarthritis. Contact Laura.Sutton@utas.edu.au or phone (03) 6226 5513.
DICKENS: A randomised controlled trial of diacerein to treat knee osteoarthritis with effusion-synovitis. We are seeking participants ages 45 – 64 with significant knee pain and localised swelling to participate in a 24 week trial to test the use of this anti-inflammatory to improve knee pain, reduce swelling and slow down the progression of knee osteoarthritis. Participants must be able to have a knee MRI and have access to email and web browsing. Contact: Kathy Buttigieg on 03 6226 6909 or Kathy.Buttigieg@utas.edu.au. Click here for more information.
Seeking GPs and orthopaedic surgeons for a short interview. The interview will focus on your perspective about the causes and progression of osteoarthritis. Your experience in the diagnosis and management of patients with osteoarthritis as well as your perspective on the role of other health professionals in the management of osteoarthritis patients. Please contact: Jen Makin on +61 3 6226 4267 or Jen.Makin@utas.edu.au
STAREE: STAtins in Reducing Events in the Elderly investigating whether a statin can prolong good health and maintain independence among people aged 70 years and older. Contact: email@example.com or 1800 770 664
QUARTET: A trial to assess the effectiveness and tolerability of ultra-low-dose quadruple combination therapy ('LDQT') in patients with hypertension. Contact: Helen.Steane@utas.edu.au or 6226-4803.
PPMS: Primary Progressive MS Study into risk factors for the onset and rate of progression of Primary Progressive MS. Contact: Alice Saul (03) 6226-4269 or firstname.lastname@example.org
AMSLS: The Australian MS Longitudinal Study to provide data of practical use for improving the lives of Australians living with MS. Contact: Kirsty Hawkes (03) 6226-4739 or AMSLS.Info@utas.edu.au, www.msra.org.au/AMSLS
OTHER DISEASE AREAS
RELIANT study is part of a larger research project which aims to increase the rate of early diagnosis of liver cancer. First, we need to understand if and why people are – or are not – having regular liver health checks to allow us to develop a new approach to support regular screening for liver health. People who have been diagnosed with viral infections of the liver, including hepatitis B and C and/or liver cirrhosis, are invited to participate in this study and will be asked to complete a confidential survey about their health and risk factors for developing liver cancer. To reach the survey go to: https://redcap.utas.edu.au/surveys/?s=J3TNAC9YED
Trips4Health: The Trips4Health study aims to test the impact of incentives to increase bus use for physical activity gain. It is hoped that this study will help more Tasmanians reach these targets and lead healthier lives because of it. For more information call 6226 4290, email email@example.com or go to Trips4Health homepage. You can find the screening survey at https://tinyurl.com/trips4health
Sedentary behaviour in primary care: We are seeking GPs to give their opinion on sedentary behaviour assessment and management in primary care. This will involve a choice of a 30-minute interview over the phone or in person at a time and place convenient for you. Contact: firstname.lastname@example.org or 6226 4267.
Standing Tall – Cognition and Gait: Randomised control trial involving a six-month home balance and cognitive training program is seeking people 60 years and over who have noticed decline in memory or thinking or have been diagnosed by a health professional with mild cognitive impairment. Must live within 50km of Hobart and not have Parkinson’s disease, multiple sclerosis or dementia. Contact: Standing.Tall@menzies.utas.edu.au or phone 03 6226 7766 and please leave contact details. For the participant information sheet click here. For the consent form click here.
Genetics of Eye Diseases for genetic studies in diabetic retinopathy (participants should have Type 2 Diabetes treated with medication for at least 5 years, or Type 1 Diabetes); keratconus (participants should have keratoconus diagnosed by an optometrist or ophthalmologist); and advanced glaucoma (participants should have any type of glaucoma with severe vision loss treated by an ophthalmologist). Contact: Jacqueline.Townley@utas.edu.au or (03) 62264731
AirRater is recruiting people in Tasmania, the ACT and the Northern Territory with asthma, hay fever or other lung conditions, or carers of those with these conditions. Contact: 1800 322 102 or email@example.com